FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

14 results

calcitriol
(Calcitriol)
Hikma Pharmaceuticals USA Inc.
Usage: Calcitriol is indicated for managing secondary hyperparathyroidism in predialysis patients with chronic renal failure, hypocalcemia in dialysis patients, and hypocalcemia related to postsurgical, idiopathic, and pseudohypoparathyroidism. It enhances calcium absorption and addresses metabolic bone disease and related health issues.
calcitriol
(Calcitriol)
Sun Pharmaceutical Industries, Inc.
Usage: Calcitriol is indicated for managing secondary hyperparathyroidism in predialysis patients with chronic renal failure, hypocalcemia in dialysis patients, and hypocalcemia related to postsurgical, idiopathic, or pseudohypoparathyroidism. It helps enhance calcium absorption and alleviate metabolic bone disease.
cinacalcet
(CINACALCET)
Cipla USA Inc.
Usage: Cinacalcet tablets are indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in patients with parathyroid carcinoma, and hypercalcemia in adults with primary hyperparathyroidism when surgery is not an option.
cinacalcet
(Cinacalcet)
Camber Pharmaceuticals, Inc.
Usage: Cinacalcet tablets are indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in parathyroid carcinoma, and severe hypercalcemia in primary hyperparathyroidism when surgery is not an option. Not indicated for non-dialysis CKD patients due to hypocalcemia risk.
cinacalcet
(Cinacalcet)
Aurobindo Pharma Limited
Usage: Cinacalcet tablets are indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, hypercalcemia in parathyroid carcinoma patients, and hypercalcemia in primary hyperparathyroidism when parathyroidectomy is not an option. Not for use in CKD patients not on dialysis due to hypocalcemia risk.
cinacalcet hydrochloride
(cinacalcet hydrochloride)
Slate Run Pharmaceuticals
Usage: Cinacalcet tablets are indicated for treating secondary hyperparathyroidism in adults with chronic kidney disease on dialysis, and for hypercalcemia in adults with parathyroid carcinoma or primary hyperparathyroidism who cannot undergo parathyroidectomy. It is not recommended for CKD patients not on dialysis due to hypocalcemia risk.
doxercalciferol
(Doxercalciferol)
Meitheal Pharmaceuticals Inc.
Usage: Doxercalciferol Injection is indicated for treating secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are on dialysis.
doxercalciferol
(Doxercalciferol)
Alembic Pharmaceuticals Inc.
Usage: Doxercalciferol Injection is indicated for treating secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are on dialysis.
doxercalciferol
(Doxercalciferol)
Amneal Pharmaceuticals LLC
Usage: Doxercalciferol injection is indicated for treating secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are undergoing dialysis.
paricalcitol
(Paricalcitol)
Amneal Pharmaceuticals LLC
Usage: Paricalcitol injection is used to prevent and treat secondary hyperparathyroidism in patients aged 5 and older with chronic kidney disease on dialysis.

Medications for Hyperparathyroidism Secondary

calcitriol

calcitriol

cinacalcet

cinacalcet

cinacalcet

cinacalcet hydrochloride

doxercalciferol

doxercalciferol

doxercalciferol

paricalcitol